Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Salarius Pharmaceuticals, Inc. | 179,848 | reported | 14 Jun 2018 | tx 5+388,498 |
| Oncorus, Inc. | 90,000 | reported | 01 Mar 2022 | tx 2+166,894 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Mar 2022 | GRANT_AWARD | Oncorus, Inc. | 90,000 | 0.00 USD | deriv |
| 01 Mar 2021 | GRANT_AWARD | Oncorus, Inc. | 76,894 | 0.00 USD | deriv |
| 14 Jun 2018 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 179,848 | 0.00 USD | deriv |
| 17 Jan 2018 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 100,000 | 0.00 USD | deriv |
| 18 Jan 2017 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 67,000 | 0.00 USD | deriv |
| 07 Nov 2016 | PURCHASE | Salarius Pharmaceuticals, Inc. | 1,650 | 6.01 USD | |
| 21 Jan 2016 | GRANT_AWARD | Salarius Pharmaceuticals, Inc. | 40,000 | 0.00 USD | deriv |